Evan Corey, MD
Sports Medicine · Greensboro, NCNPI 1801116884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Amgen at 24.8% of the total. Reporting peaked in 2019 at $781 and has fallen 76.9% since, to $180 in 2025.
Across 123 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$455
- Novo Nordisk$177
- Pfizer$140
- AstraZeneca$127
- Radius Health, Inc.$91
- Johnson & Johnson$90
- plus $756 from 21 others
What the payments were for
- Food & beverage$1,837100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 30 | $455 |
| Novo Nordisk | 16 | $177 |
| Pfizer | 10 | $140 |
| AstraZeneca | 10 | $127 |
| Radius Health, Inc. | 4 | $91 |
| Johnson & Johnson | 3 | $90 |
| GSK | 5 | $86 |
| Lilly USA, LLC | 6 | $78 |
| Supernus Pharmaceuticals, Inc. | 5 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Boehringer Ingelheim | 4 | $55 |
| Merck | 4 | $54 |
| Eisai Inc. | 3 | $53 |
| Almatica Pharma LLC | 2 | $39 |
| Astellas Pharma US Inc | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| ERMI LLC | 1 | $23 |
| Novartis | 2 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| AbbVie | 1 | $22 |
| Boston Scientific | 1 | $20 |
| Tenex Health Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,837 in reported general payments places this provider in the 55th percentile of 158 sports medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 206 | $1,743 |
| Tizanidine Hcl | 91 | $972 |
| Colchicine | 34 | $808 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $660 |
| Pregabalin | 36 | $497 |
| Celecoxib | 33 | $432 |
| Allopurinol | 55 | $431 |
| Alendronate Sodium | 31 | $392 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $346 |
| Nortriptyline Hcl | 27 | $227 |
| Baclofen | 16 | $179 |
| Prednisone | 67 | $148 |
| Duloxetine Hcl | 20 | $134 |
| Topiramate | 14 | $95 |
| Tramadol Hcl | 41 | $92 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Greensboro
- Rebecca BassettGreensboro$69K
- Alan ReynoldsGreensboro$54K
- Nathan WhiteGreensboro$34K
- Bradley WhamGreensboro$31K
- Jason RogersGreensboro$14K
- Thomas ThekkekandamGreensboro$11K
- Kevin SuppleGreensboro$6K
- Brian WatermanWinston Salem$360K
- Allston StubbsWinston Salem$184K
- Robert BoykinAsheville$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.